rufinamide has been researched along with Vomiting in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergin, AM; Bolton, J; Bourgeois, BF; Harini, C; Kadish, NE; Kapur, K; Kothare, SV; Libenson, M; Loddenkemper, T; Olson, H; Peters, J; Poduri, A; Ramgopal, S; Rotenberg, A; Sánchez Fernández, I; Takeoka, M; Thome-Souza, S | 1 |
Becerra, JL; Burcet, J; Cano, A; Falip, M; Fernández, S; Fossas, P; Jaraba, S; Miravet, E; Miró, J; Molins, A; Pico, G; Raspall, M; Santamarina, E; Toledo, M | 1 |
Conry, J; Krauss, G; LoPresti, A; Mann, A; Narurkar, M; Wheless, JW | 1 |
1 review(s) available for rufinamide and Vomiting
Article | Year |
---|---|
Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
Topics: Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Clinical Trials as Topic; Disorders of Excessive Somnolence; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Headache; Humans; Male; Treatment Outcome; Triazoles; Vomiting | 2009 |
2 other study(ies) available for rufinamide and Vomiting
Article | Year |
---|---|
Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Male; Patient Compliance; Prospective Studies; Retrospective Studies; Sleep Wake Disorders; Treatment Outcome; Triazoles; Vomiting; Young Adult | 2014 |
Rufinamide in children and adults in routine clinical practice.
Topics: Adolescent; Adult; Anticonvulsants; Child; Epilepsy, Generalized; Female; Humans; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Triazoles; Vomiting; Weight Loss | 2017 |